Study Conduct

Mosio launches suite of patient recruitment and retention solutions

Monday, June 15, 2015 01:15 PM

Mosio, a San Francisco, Calif.-based life science technology company, has launched a suite of solutions created specifically for each type of organization within the clinical research ecosystem. Mosio’s web-based mobile messaging software services to enhance clinical trial recruitment and retention range from targeted plans for principal investigators and study sites to broad capabilities for CROs and fully customizable solutions for integration into study platforms of study sponsors, patient recruitment firms and trial technology enterprises.

More... »


OpenClinica releases Participate to capture research data directly from patients

Thursday, June 11, 2015 11:57 AM

OpenClinica, a Boston-based provider of software for electronically capturing clinical research data, has launched Participate, a mobile, device independent solution for engaging participants in clinical research. Participate broadens possibilities for clinical research, by making it easier to meaningfully engage patients and collect high quality, timely data from patients in a way that is convenient for them.

More... »


INC Research launches site advocacy group to enhance the clinical research process

Wednesday, June 10, 2015 11:17 AM

Global CRO INC Research has launched a Site Advocacy Group (SAG) devoted to the scientific and operational aspects of clinical research. The SAG initially will focus on central nervous system (CNS) protocols—recognized as among the more complex therapeutic areas in clinical research—targeting psychiatry studies including, but not limited to, those in schizophrenia, attention-deficit/hyperactivity disorder (ADHD), depression and bipolar disorder.

More... »

Certara endows lectureship in precision dosing at University of Manchester

Thursday, June 4, 2015 08:16 AM

Certara, a global biosimulation technology-enabled drug development consultancy, is endowing a new three-year, full-time position—the Certara lecturer in precision dosing—at the Manchester Pharmacy School, the University of Manchester, England. This lectureship is intended to advance teaching and research into individual dose optimization modeling, and to demonstrate its application to cancer, pediatric and biologic therapies.

More... »

Guardian Research Network, Molecular Health to expand trial access for cancer patients

Monday, June 1, 2015 10:45 AM

The Guardian Research Network, a nationwide consortium of community health systems based in Spartanburg, S.C., and Molecular Health, a biomedical company headquartered in Heidelberg, Germany, have announced a collaboration designed to provide therapeutic clinical trial access and molecular diagnostic decision support to the majority of cancer patients living in U.S. communities.

More... »

Clinerion, ACRES partner on patient recruitment, risk-based quality management

Thursday, May 28, 2015 03:10 PM

Clinerion, an eClinical technology services provider located in Basel, Switzerland, and the Alliance for Clinical Research Excellence and Safety (ACRES), a Cambridge, Mass.-based nonprofit, have partnered for accelerating patient recruitment and promoting risk-based quality management.

More... »

CISCRP Medical Heroes Appreciation event returns to DIA to celebrate clinical trial volunteers

Wednesday, May 27, 2015 01:38 PM

The Center for Information and Study on Clinical Research Participation (CISCRP), an independent nonprofit organization, has announced the upcoming Medical Heroes Appreciation Walk in Washington D.C. to honor the volunteers who give the gift of participation in clinical research and to raise awareness about the importance of clinical research in advancing public health.

More... »

Center for Biomedical Research, Ackerman Cancer Center partner on clinical registry

Friday, May 22, 2015 01:47 PM

The Center for Biomedical Research (CBR) is partnering with Ackerman Cancer Center, a new proton therapy center, as part of a clinical meta-registry for clinical outcomes and long-term follow-up of cancer patients receiving proton therapy.

More... »

Verified Clinical Trials, Integreview IRB create new expedited research subject authorization review process

Thursday, May 21, 2015 07:35 AM

Verified Clinical Trials (VCT) and Integreview IRB have developed a preferred partnership to stop dual enrollment in clinical trials and reduce protocol deviations while promoting safety. Research sites, CROs and pharmaceutical sponsors will benefit from this alliance in an effort to stop dual enrollment in clinical trials and reduce significant protocol violations from occurring. 

More... »

WCG, Certara co-sponsor Lasker Lessons in Leadership events

Wednesday, May 20, 2015 03:20 PM

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services and software to support clinical research, and Certara, a global biosimulation technology-enabled drug development consultancy, are co-sponsoring the inaugural Lasker Lessons in Leadership, a series of one-day career-oriented workshops for postgraduate medical research students. This program, which has been developed by the Albert and Mary Lasker Foundation in collaboration with the International Biomedical Research Alliance and the NIH Oxford-Cambridge Scholars Program, began May 19 at the NIH Main Campus in Bethesda, Md.

More... »

CWWeekly

July 6

FDA sued by advocacy groups seeking hepatitis C trials data

Google to test health-tracking wristband to collect clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs